Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.40 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.37 |
| ▸ | PRKDC | P78527 | 6/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | KRAS | P01116 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16553306 | 0.97 | PARP14 (0.41) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL12268504 | 0.94 | PARP14 (0.41) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL18777363 | 0.94 | PARP14 (0.41) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL12268368 | 0.94 | PARP14 (0.41) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL12268444 | 0.94 | PARP14 (0.41) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL18777323 | 0.94 | PARP14 (0.41) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL12268626 | 0.93 | PARP14 (0.40) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL18777361 | 0.93 | PARP14 (0.40) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL18777384 | 0.93 | PARP14 (0.40) | ALOX5PARP14LIMK1CDK5CDK5R1 | |
| SCHEMBL16558223 | 0.93 | PARP14 (0.40) | ALOX5PARP14LIMK1CDK5CDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10224490-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2019-03-05 | — | — | US | disclosed |
| US-20180130958-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130958-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9096578-B2 | Dibenzol[f,h]quinoxaline compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-08-04 | — | — | US | disclosed |
| US-9096578-B2 | Dibenzol[f,h]quinoxaline compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-08-04 | — | — | US | disclosed |
| US-20130112954-A1 | Dibenzo[f,h]Quinoxaline Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130112954-A1 | Dibenzo[f,h]Quinoxaline Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130958-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | NQO1, DDT, CYP1A1 | ALOX5 637/4885PARP14 2721/4885LIMK1 536/4885 |
| US-10224490-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | NQO1, DDT, CYP1A1 | ALOX5 637/4885PARP14 2721/4885LIMK1 536/4885 |
| US-20130112954-A1 | Dibenzo[f,h]Quinoxaline Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | DDT, PDXK, DDX41 | ALOX5 623/4885PARP14 1107/4885LIMK1 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.